Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Articles and issues > Author index
Search
Sharon Lim 3 Articles
Secretory Carcinoma Arising in a Fibroadenoma: A Brief Case Report
Sharon Lim, Min Keun Shim, Eun Yoon Cho, Soo Youn Cho
J Pathol Transl Med. 2018;52(3):198-201.   Published online October 4, 2017
DOI: https://doi.org/10.4132/jptm.2017.08.01
  • 5,385 View
  • 112 Download
PDF
Significance of Parafibromin Expression in Laryngeal Squamous Cell Carcinomas
Inju Cho, Mija Lee, Sharon Lim, Ran Hong
J Pathol Transl Med. 2016;50(4):264-269.   Published online June 23, 2016
DOI: https://doi.org/10.4132/jptm.2016.04.24
  • 8,335 View
  • 58 Download
  • 5 Web of Science
  • 3 Crossref
AbstractAbstract PDF
Background
Parafibromin is a product of the tumor suppressor gene that has been studied as a potential indicator of tumor aggressiveness in the parathyroid, breast, colorectum, and stomach. However, the clinical significance and potential function of parafibromin expression in head and neck squamous cell carcinomas remain largely unknown. The aim of this study was to evaluate the expression of parafibromin in laryngeal squamous cell carcinoma (LSCC) and to verify its potential as a biomarker of tumor behavior.
Methods
Parafibromin expression was evaluated in 30 cases of LSCC using immunohistochemistry. The correlations between parafibromin expression and clinicopathologic parameters were investigated.
Results
Parafibromin expression was positive in 15 cases (50%) and negative in 15 cases (50%). Tumor size and T stage showed a statistically significant inverse relationship with parafibromin expression (p=.028 and p<.001, respectively). Parafibromin expression was not associated with age, sex, lymph node metastasis, tumor differentiation, or tumor location. There was no statistically significant relationship between parafibromin expression and progression-free survival in the patients (p>.05).
Conclusions
Our results indicate that the downregulation or loss of parafibromin expression can be employed as a novel marker of tumor progression or aggressiveness in LSCC.

Citations

Citations to this article as recorded by  
  • Advances in the application of labelā€free quantitative proteomics techniques in malignancy research
    Xiao Meng, Dong Liu, Yan Guan
    Biomedical Chromatography.2023;[Epub]     CrossRef
  • The roles of the tumor suppressor parafibromin in cancer
    Hua-chuan Zheng, Hang Xue, Cong-yu Zhang
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • The clinicopathological and prognostic significances of CDC73 expression in cancers: a bioinformatics analysis
    Hua-Chuan Zheng, Bao-Cheng Gong, Shuang Zhao
    Oncotarget.2017; 8(56): 95270.     CrossRef
Digital Papillary Carcinoma
Sharon Lim, Inju Cho, Mi Ja Lee
Korean J Pathol. 2014;48(6):438-441.   Published online December 31, 2014
DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.6.438
  • 8,035 View
  • 44 Download
  • 2 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Digital papillary adenocarcinoma: A case report
    Betty A. Kasimo, Vivian Akello, James J. Yahaya
    Clinical Case Reports.2021;[Epub]     CrossRef
  • A rare case of a digital papillary carcinoma of the hand with secondary conservative management
    Rabeet Khan, Renu Irri, Effie Katsarma
    Journal of Surgical Case Reports.2020;[Epub]     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine